Optellum Lung Cancer Prediction (LCP) AI vs. RevealDx mSI

Lung nodule care doesn’t stop at the radiology report. So why should the AI?

Incidental lung nodules are managed by multidisciplinary teams, not one specialty alone. Our LCP AI remains the only FDA-cleared AI risk stratification solution indicated for both pulmonologists and radiologists. ^{1, 2, 3}

Because earlier diagnosis and earlier intervention are team sports.

See us at 🎯 Booth #2303 at ATS 2026 and learn why leading Incidental Lung Nodule and Lung Cancer Care programs in the US continue to use Optellum AI.

Sources:
[1] Optellum: K202300
[2] RevealDx: K251769
[3] Optellum publications